Silicon Laboratories Inc., a fabless semiconductor company, provides mixed-signal analog intensive products in the United States, China, Taiwan, and internationally.
Screened 2026-09-11 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Silicon Laboratories Inc. holds its Accumulation at $220.33. Consolidating, no directional conviction, held for 57 days.
As held on the ledger · 2026-09-11
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 57 days
Price at the screen
$220.33
Valuation
N/A trailing · 50.52 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.36
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
1.89%
Below 33%
Interest-bearing debt is just 1.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
6.26%
Below 33%
Cash held in interest-bearing accounts and securities is 6.3% of assets, under the one-third limit.
Pass
Receivables
33.78%
Below 49%
Money owed to the company is 33.8% of assets, under the 49% limit.
Pass
Revenue purity
1.73%
Below 5%
Only 1.7% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 39.2% above the base estimate.
Third-party analyst targets: 7 covering, consensus None. The average target sits +5% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Premium price tag on a loss making chipmaker
Picture a foundry that only hums when the economy is roaring yet still demands top dollar even as orders slow. Silicon Laboratories sits in exactly that spot. Revenue may be rising at 20 percent but the firm is losing money, margins sit at minus 6 percent and return on equity is negative. The shares trade at 52 times forward earnings against a fair value more than 60 dollars below the current price, so the market is already paying for a boom that has not arrived.
This is the classic cyclical trap. Low or negative profits paired with a sky high multiple often signal that earnings are near a peak and will fall when the cycle turns. No clear moat cushions the blow and the opportunity rating is none. The ethical screen is passed but valuation and industry swings outweigh that single green light.
Risk sits with the macro outlook for industrial and consumer electronics. Any slowdown will hit orders hard and the current price leaves little room for disappointment. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SLAB trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-13Accumulation$220.33+0.9%Entry 5
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (7 analysts) rates it hold, with a mean price target of $223.
2026-08-13Accumulation$218.47-0.5%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (7 analysts) rates it hold, with a mean price target of $223.
2026-07-18Accumulation$219.51+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (7 analysts) rates it hold, with a mean price target of $223.
2026-07-03Accumulation$219.51+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Accumulation$219.51Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
